Current and Emerging Treatments for Alpha-1 Antitrypsin Deficiency.
Author:
- 1 July 2016
- journal article
- Vol. 12 (7) , 446-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Two New Considerations for Improving the Diagnosis of α1-Antitrypsin Deficiency-Associated Liver DiseaseDigestive Diseases and Sciences, 2015
- Mysteries of α1-antitrypsin deficiency: emerging therapeutic strategies for a challenging diseaseDisease Models & Mechanisms, 2014
- Capitalizing on the Autophagic Response for Treatment of Liver Disease Caused by Alpha-1-Antitrypsin Deficiency and Other Genetic DiseasesBioMed Research International, 2014
- Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin–related liver disease in miceJournal of Clinical Investigation, 2013
- Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cellsNature, 2011
- An Autophagy-Enhancing Drug Promotes Degradation of Mutant α 1 -Antitrypsin Z and Reduces Hepatic FibrosisScience, 2010
- Alpha-1-Antitrypsin Deficiency: Outcomes After Liver TransplantationTransplantation Proceedings, 2008
- Liver Carcinoma in PiZ Alpha-1-Antitrypsin DeficiencyAmerican Journal of Surgical Pathology, 1998
- Risk of Cirrhosis and Primary Liver Cancer in Alpha1-Antitrypsin DeficiencyNew England Journal of Medicine, 1986